(PharmaNewsWire.Com, June 14, 2017 ) The major drivers that are fostering the market growth include rising number of surgical procedures, increasing count of specialty hospitals, and attracting end-users through involvement in medical exhibitions. However, high cost of open surgeries is restricting the market size. Hospitals and Clinics segment accounted for highest revenue owing to rising number of entries to hospitals for surgical care. North America commanded the largest market share during the forecast period attributed to rising adoption of anesthesia vaporizers by hospital outpatient settings.
Some of the key players in this market include GE Healthcare, Meditec International England, Spacelabs Healthcare, Beijing Vanbonmed, OES Medical, Drägerwerk AG & Co. KGaA, Penlon Limited Oricare Inc, Beijing Siriusmed Medical Device, CM-CC, NorVap, Beijing Yi Shiheng Electronic Technology, Medtronic plc, Piramal Healthcare and SkyePharma Inc.
End Users Covered: - Ambulatory surgical centers (ASCs) - Hospitals and clinics - Physician offices
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
10 Company Profiling 10.1 GE Healthcare 10.2 Meditec International England 10.3 Spacelabs Healthcare 10.4 Beijing Vanbonmed 10.5 OES Medical 10.6 Drägerwerk AG & Co. KGaA 10.7 Penlon Limited 10.8 Oricare Inc. 10.9 Beijing Siriusmed Medical Device 10.10 CM-CC 10.11 NorVap 10.12 Beijing Yi Shiheng Electronic Technology 10.13 Medtronic plc 10.14 Piramal Healthcare 10.15 SkyePharma Inc.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
